Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–7. https://doi.org/10.1016/j.healun.2020.03.012.

Article  PubMed  PubMed Central  Google Scholar 

Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, Ho YL, Iyengar SK, Kosik NM, Vujkovic M, Gagnon DR, Bento AP, Barrio-Hernandez I, Rönnblom L, Hagberg N, Lundtoft C, Langenberg C, Pietzner M, Valentine D, Gustincich S, Tartaglia GG, Allara E, Surendran P, Burgess S, Zhao JH, Peters JE, Prins BP, Angelantonio ED, Devineni P, Shi Y, Lynch KE, DuVall SL, Garcon H, Thomann LO, Zhou JJ, Gorman BR, Huffman JE, O'Donnell CJ, Tsao PS, Beckham JC, Pyarajan S, Muralidhar S, Huang GD, Ramoni R, Beltrao P, Danesh J, Hung AM, Chang KM, Sun YV, Joseph J, Leach AR, Edwards TL, Cho K, Gaziano JM, Butterworth AS, Casas JP, VA Million Veteran Program COVID-19 Science Initiative. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med. 2021;27(4):668–676. https://doi.org/10.1038/s41591-021-01310-z

Ng YL, Salim CK, Chu JJH. Drug repurposing for COVID-19: approaches, challenges and promising candidates. Pharmacol Ther. 2021;228:107930. https://doi.org/10.1016/j.pharmthera.2021.107930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weis N, Bollerup S, Sund JD, Glamann JB, Vinten C, Jensen LR, Sejling C, Kledal TN, Rosenkilde MM. Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial. Clin Microbiol Infect. 2023;29(10):1313–9. https://doi.org/10.1016/j.cmi.2023.06.023.

Article  CAS  PubMed  Google Scholar 

Cheema HA, Jafar U, Shahid A, Masood W, Usman M, Hermis AH, Naseem MA, Sahra S, Sah R, Lee KY. Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2024;14(4): e074373. https://doi.org/10.1136/bmjopen-2023-074373.

Article  PubMed  PubMed Central  Google Scholar 

WHO COVID-19 Solidarity Therapeutics Trial. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments, 2021. Accessed 11 March 2025.

Recovery trial. https://www.recoverytrial.net/, 2023. Accessed 11 March 2025.

Godwin PO, Polsonetti B, Caron MF, Oppelt TF. Remdesivir for the treatment of COVID-19: a narrative review. Infect Dis Ther. 2024;13(1):1–19. https://doi.org/10.1007/s40121-023-00900-3.

Article  PubMed  PubMed Central  Google Scholar 

European Centre for Disease Prevention and Control (ECDC). Antiviral treatment of influenza. https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/antivirals, 2023. Accessed 11 March 2025.

Seow HC, Liao Q, Lau ATY, Leung SWS, Yuan S, Lam JKW. Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration. Int J Pharm. 2022;619: 121704. https://doi.org/10.1016/j.ijpharm.2022.121704.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sonvico F, Colombo G, Quarta E, Guareschi F, Banella S, Buttini F, Scherließ R. Nasal delivery as a strategy for the prevention and treatment of COVID-19. Expert Opin Drug Deliv. 2023;20(8):1115–30. https://doi.org/10.1080/17425247.2023.2263363.

Article  CAS  PubMed  Google Scholar 

Muñoz-Prieto A, Contreras-Aguilar MD, Cerón JJ, Ayala I, Martin-Cuervo M, Gonzalez-Sanchez JC, Jacobsen S, Kuleš J, Beletić A, Rubić I, Mrljak V, Tecles F, Hansen S. Changes in proteins in saliva and serum in Equine gastric ulcer syndrome using a proteomic approach. Animals. 2022;12(9):1169. https://doi.org/10.3390/ani12091169.

Article  PubMed  PubMed Central  Google Scholar 

Shilts MH, Rosas-Salazar C, Strickland BA, Kimura KS, Asad M, Sehanobish E, Freeman MH, Wessinger BC, Gupta V, Brown HM, Boone HH, Patel V, Barbi M, Bottalico D, O’Neill M, Akbar N, Rajagopala SV, Mallal S, Phillips E, Turner JH, Jerschow E, Das SR. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome. Front Cell Infect Microbiol. 2022;11:781968. https://doi.org/10.3389/fcimb.2021.781968.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilding RJ, Thynne M, Subhan MMF. Optimization of sniff nasal inspiratory pressure (SNIP) measurement methodology in healthy subjects. BMC Pulm Med. 2023;23:66. https://doi.org/10.1186/s12890-023-02348-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect Dis. 2003;3(11):722–7. https://doi.org/10.1016/s1473-3099(03)00806-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meo SA, Klonoff DC, Akram J. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci. 2020;24(8):4539–47. https://doi.org/10.26355/eurrev_202004_21038.

Article  CAS  PubMed  Google Scholar 

Carafoli E. Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection. Biochem Biophys Res Commun. 2021;538:156–62. https://doi.org/10.1016/j.bbrc.2020.09.128.

Article  CAS  PubMed  Google Scholar 

Martinelli F, Balducci AG, Rossi A, Sonvico F, Colombo P, Buttini F. Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs. Int J Pharm. 2015;487(1–2):197–204. https://doi.org/10.1016/j.ijpharm.2015.04.003.

Article  CAS  PubMed  Google Scholar 

Cui C, Zhang M, Yao X, Tu S, Hou Z, Jie En VS, Xiang X, Lin J, Cai T, Shen N, Song C, Qiao J, Zhang S, Li H, Liu D. Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model. Acta Pharm Sin B. 2020;10(7):1216–27. https://doi.org/10.1016/j.apsb.2020.04.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buttini F, Cuoghi E, Miozzi M, Rossi A, Sonvico F, Colombo P. Insulin spray-dried powder and smoothed lactose: a new formulation strategy for nasal and pulmonary delivery. Respir Drug Deliv. 2012;3:835–40.

Google Scholar 

Müller D, Fimbinger E, Brand C. Algorithm for the determination of the angle of repose in bulk material analysis. Powder Technol. 2021;383:598–605. https://doi.org/10.1016/j.powtec.2021.01.010.

Article  CAS  Google Scholar 

Quarta E, Chierici V, Flammini L, Tognolini M, Barocelli E, Cantoni AM, Dujovny G, Ecenarro Probst S, Sonvico F, Colombo G, Rossi A, Bettini R, Colombo P, Buttini F. Excipient-free pulmonary insulin dry powder: pharmacokinetic and pharmacodynamics profiles in rats. J Control Release. 2020;323:412–20. https://doi.org/10.1016/j.jconrel.2020.04.015.

Article  CAS  PubMed  Google Scholar 

Buttini F, Balducci AG, Colombo G, Sonvico F, Montanari S, Pisi G, Rossi A, Colombo P, Bettini R. Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy. Int J Pharm. 2018;548(1):182–91. https://doi.org/10.1016/j.ijpharm.2018.06.006.

Article  CAS  PubMed  Google Scholar 

Balducci AG, Ferraro L, Bortolotti F, Nastruzzi C, Colombo P, Sonvico F, Russo P, Colombo G. Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats. Int J Pharm. 2013;440(2):154–60. https://doi.org/10.1016/j.ijpharm.2012.09.049.

Article  CAS  PubMed  Google Scholar 

Tiozzo Fasiolo L, Manniello MD, Bortolotti F, Buttini F, Rossi A, Sonvico F, Colombo P, Valsami G, Colombo G, Russo P. Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease. J Drug Target. 2019;27(9):984–94. https://doi.org/10.1080/1061186X.2019.1574300.

Article  CAS  PubMed  Google Scholar 

Choi KY, Cho SW, Choi JJ, Zhang YL, Kim DW, Han DH, Kim HJ, Kim DY, Rhee CS, Won TB. Healing of the nasal septal mucosa in an experimental rabbit model of mucosal injury. World Journal of Otorhinolaryngology. 2017;3(1):17–23. https://doi.org/10.1016/j.wjorl.2017.02.004.

Article  Google Scholar 

Johnson TJ, Nishida RT, Sonpar AP, Lin YJ, Watson KA, Smith SW, Conly JM, Evans DH, Olfert JS. Viral load of SARS-CoV-2 in droplets and bioaerosols directly captured during breathing, speaking and coughing. Sci Rep. 2022;12(1):3484. https://doi.org/10.1038/s41598-022-07301-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pujadas E, Chaudhry F, McBride R, Richter F, Zhao S, Wajnberg A, Nadkarni G, Glicksberg BS, Houldsworth J, Cordon-Cardo C. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8(9):e70. https://doi.org/10.1016/S2213-2600(20)30354-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marc A, Kerioui M, Blanquart F, Bertrand J, Mitjà O, Corbacho-Monné M, Marks M, Guedj J. Quantifying the relationship between SARS-CoV-2 viral load and infectiousness. Elife. 2021;10: e69302. https://doi.org/10.7554/eLife.69302.

Article